• Citer

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform

par Nguyen, Jennifer J.L.;Mitratza, Marianna;Volkman, Hannah H.R.;de Munter, Leonie;Tran, Thao Mai Phuong;Marques, Catia;Mustapha, Mustapha;Valluri, Srinivas;Yang, Jingyan;Antón, Andrés;Casas, Irma;Conde-Sousa, Eduardo;Drikite, Laura;Grüner, Beate;Icardi, Giancarlo;ten Kate, Gerrit Luit;Martin, Charlotte ;Mira-Iglesias, Ainara;Orrico-Sánchez, Alejandro;Otero-Romero, Susana;Rohde, Gernot;Jodar, Luis;McLaughlin, John J.M.;Bollaerts, Kaatje
Référence EClinicalMedicine, 79, 102995
Publication Publié, 2025-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
Auteur:	Nguyen, Jennifer J.L.; Mitratza, Marianna; Volkman, Hannah H.R.; de Munter, Leonie; Tran, Thao Mai Phuong; Marques, Catia; Mustapha, Mustapha; Valluri, Srinivas; Yang, Jingyan; Antón, Andrés; Casas, Irma; Conde-Sousa, Eduardo; Drikite, Laura; Grüner, Beate; Icardi, Giancarlo; ten Kate, Gerrit Luit; Martin, Charlotte; Mira-Iglesias, Ainara; Orrico-Sánchez, Alejandro; Otero-Romero, Susana; Rohde, Gernot; Jodar, Luis; McLaughlin, John J.M.; Bollaerts, Kaatje
Informations sur la publication:	EClinicalMedicine, 79, 102995
Statut de publication:	Publié, 2025-01
Sujet CREF:	Généralités
Mots-clés:	BNT162b2
	COVID-19
	COVID-19 vaccination
	JN.1
	SARS-CoV-2
	Vaccine effectiveness
	XBB adapted vaccine
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2589-5370
	info:doi/10.1016/j.eclinm.2024.102995
	info:pii/S2589537024005741
	info:scp/85211043638